OA08710A - Sel de sodium de 5-chloro-3-(2-thénoyl)-2-oxindole-1-carboxamide anhydre cristallin, son procédé de préparation et composition pharmaceutique le contenant. - Google Patents

Sel de sodium de 5-chloro-3-(2-thénoyl)-2-oxindole-1-carboxamide anhydre cristallin, son procédé de préparation et composition pharmaceutique le contenant.

Info

Publication number
OA08710A
OA08710A OA59273A OA59273A OA08710A OA 08710 A OA08710 A OA 08710A OA 59273 A OA59273 A OA 59273A OA 59273 A OA59273 A OA 59273A OA 08710 A OA08710 A OA 08710A
Authority
OA
OAPI
Prior art keywords
thenoyl
oxindole
chloro
preparation
pharmaceutical composition
Prior art date
Application number
OA59273A
Other languages
English (en)
French (fr)
Inventor
Allen Douglas John Meldrum
O'neil Brian Thomas
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA08710A publication Critical patent/OA08710A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA59273A 1987-02-02 1988-02-01 Sel de sodium de 5-chloro-3-(2-thénoyl)-2-oxindole-1-carboxamide anhydre cristallin, son procédé de préparation et composition pharmaceutique le contenant. OA08710A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (1)

Publication Number Publication Date
OA08710A true OA08710A (fr) 1989-03-31

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59273A OA08710A (fr) 1987-02-02 1988-02-01 Sel de sodium de 5-chloro-3-(2-thénoyl)-2-oxindole-1-carboxamide anhydre cristallin, son procédé de préparation et composition pharmaceutique le contenant.

Country Status (42)

Country Link
US (1) US5036099A (de)
EP (1) EP0277738B1 (de)
JP (1) JPS63201184A (de)
KR (1) KR900001422B1 (de)
CN (1) CN1022324C (de)
AP (1) AP52A (de)
AR (1) AR243182A1 (de)
AT (1) ATE73800T1 (de)
AU (1) AU587736B2 (de)
BG (1) BG51042A3 (de)
CA (1) CA1335590C (de)
CS (2) CS265250B2 (de)
CY (1) CY1775A (de)
DD (1) DD267490A5 (de)
DE (1) DE3869149D1 (de)
DK (1) DK44888A (de)
EC (1) ECSP941082A (de)
ES (1) ES2032955T3 (de)
FI (1) FI89598C (de)
GR (1) GR3004200T3 (de)
HK (1) HK132695A (de)
IE (1) IE60000B1 (de)
IL (1) IL85277A (de)
IN (1) IN171799B (de)
IS (1) IS1533B (de)
LV (1) LV10252B (de)
MA (1) MA21171A1 (de)
MY (1) MY102737A (de)
NO (1) NO170581C (de)
NZ (1) NZ223373A (de)
OA (1) OA08710A (de)
PH (1) PH26545A (de)
PL (1) PL149550B1 (de)
PT (1) PT86675B (de)
RO (1) RO105052B1 (de)
RU (1) RU2011381C1 (de)
SG (1) SG27994G (de)
SI (1) SI8810183A8 (de)
UA (1) UA25898A1 (de)
WO (1) WO1988005656A1 (de)
YU (1) YU46766B (de)
ZA (1) ZA88679B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
SK278175B6 (en) * 1988-10-18 1996-03-06 Pfizer 3-acyl-2-oxindole-1-carboxamides and method of their preparation
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (de) * 1996-08-21 1998-03-04 Pfizer Inc. Stabile, lange aktive Salze von Carboxamiden für die Behandlung von Gelenkskrankheiten
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) * 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
BR112020008852A2 (pt) 2017-11-02 2020-10-20 Accurate Medical Therapeutics Ltd. cateter para embolização com filtro integrado

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
ATE63543T1 (de) * 1984-02-07 1991-06-15 Pfizer 2-oxindolzwischenprodukte.
PT80116B (pt) * 1984-03-19 1987-10-20 Pfizer Processo para a producao de 2-oxindole-1-carboxamidas e de intermediarios para esse efeito
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
KR900001422B1 (ko) 1990-03-09
IN171799B (de) 1993-01-09
RU2011381C1 (ru) 1994-04-30
DK44888A (da) 1988-08-03
JPH0576945B2 (de) 1993-10-25
DD267490A5 (de) 1989-05-03
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
HK132695A (en) 1995-09-01
ATE73800T1 (de) 1992-04-15
FI89598B (fi) 1993-07-15
CY1775A (en) 1996-04-05
NZ223373A (en) 1989-06-28
MA21171A1 (fr) 1988-10-01
US5036099A (en) 1991-07-30
EP0277738B1 (de) 1992-03-18
IS3309A7 (is) 1988-08-03
FI893647A0 (fi) 1989-08-01
IE880269L (en) 1988-08-02
PH26545A (en) 1992-08-19
CA1335590C (en) 1995-05-16
DK44888D0 (da) 1988-01-29
WO1988005656A1 (en) 1988-08-11
NO884329D0 (no) 1988-09-29
SI8810183A8 (sl) 1996-08-31
ECSP941082A (es) 1994-12-15
MY102737A (en) 1992-09-30
ES2032955T3 (es) 1996-07-16
AR243182A1 (es) 1993-07-30
PL270415A1 (en) 1988-12-08
NO170581C (no) 1992-11-04
UA25898A1 (uk) 1999-02-26
NO170581B (no) 1992-07-27
PL149550B1 (en) 1990-02-28
CS354191A3 (en) 1992-04-15
PT86675B (pt) 1992-07-31
AU587736B2 (en) 1989-08-24
YU46766B (sh) 1994-05-10
NO884329L (no) 1988-09-29
DE3869149D1 (de) 1992-04-23
IL85277A0 (en) 1988-07-31
EP0277738A1 (de) 1988-08-10
CN1022324C (zh) 1993-10-06
IS1533B (is) 1994-01-28
AP52A (en) 1989-09-16
IE60000B1 (en) 1994-05-18
KR880009961A (ko) 1988-10-06
AP8800081A0 (en) 1987-11-01
CN88100555A (zh) 1988-08-17
CS64888A2 (en) 1988-08-16
ZA88679B (en) 1989-09-27
PT86675A (pt) 1988-03-01
LV10252A (lv) 1994-10-20
SG27994G (en) 1994-10-14
CS265250B2 (en) 1989-10-13
GR3004200T3 (de) 1993-03-31
BG51042A3 (en) 1993-01-15
IL85277A (en) 1994-02-27
YU18388A (en) 1989-10-31
AU1116088A (en) 1988-08-04
FI89598C (fi) 1993-10-25
RO105052B1 (en) 1994-12-01

Similar Documents

Publication Publication Date Title
OA08710A (fr) Sel de sodium de 5-chloro-3-(2-thénoyl)-2-oxindole-1-carboxamide anhydre cristallin, son procédé de préparation et composition pharmaceutique le contenant.
FR2603584B1 (fr) Nouveaux composes benzoheterocycliques utiles comme agents antimicrobiens, procede pour leur preparation et medicament les contenant
PT78340A (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
PT85279A (fr) Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant
OA06797A (fr) Composé de platine, procédé de préparation et compositions pharmaceutiques en contenant.
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
PH25741A (en) Heterocyclic compounds, pharmaceutical composition containing said compound, method of use thereof
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
OA09442A (fr) Dérivés de la thiéno-triazolo-diazépine, un procédé pour leur préparation et compositions thérapeutiques en contenant.
BE847274A (fr) Nouveau sel de prostaglandine, son procede de preparation et composition pharmaceutique le contenant
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
FR2605004B1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
FR2496461B1 (fr) Procede de preparation de comprimes analgesiques, directement compressibles, d'acetaminophene renfermant de la carboxymethylcellulose sodique et nouveaux produits ainsi obtenus
OA07521A (fr) Nicotonamide 1-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant.
MA19731A1 (fr) Isomere levogyre de la mequitazine , son procede de praparation et medicaments le contenant .
OA09201A (fr) "Dérivés sulfonyles de la thiéno-triazolo-diazépine, un procédé pour leur préparation et des compositions thérapeutiques en contenant".
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
OA08699A (fr) Aminopropionamides substitués, procédé pour leur préparation, produits les contenat et leur utilisation, ainsi que de nouveaux produit intermediaires pour leur préparation.
MC2049A1 (fr) Nouveaux composes chimiques,procede de preparation desdits composes et compositions pharmaceutiques utiles pour des traitements bronchopulmonaires les contenant
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
OA08734A (fr) Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant.
PT87634A (pt) Process for the preparation of pharmaceutical compositions containing n-imidazolyl derivatives of bicyclic compounds useful for the treatment of nephrophies
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
FR2595697B1 (fr) Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
HUT48585A (en) Process for production of perhydrobenz /c,d/ sulphonamids and medical preparatives containing these compounds as active substance